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Abstract 
Introduction: Solid-organ transplant recipients are at risk of hepatitis E virus (HEV) infection. We analyzed the seroprevalence/
risk factors of HEV in Croatian liver transplant recipients. Methods: Two hundred forty-two serum samples were tested for 
HEV immunoglobuline IgG/IgM and HEV RNA. Sociodemographic data and risk factors were collected using a questionnaire. 
Results: HEV IgG seroprevalence rate was 24.4%. Positive/equivocal HEV IgM were found in two patients. HEV RNA was not 
detected. Logistic regression showed that older age, female gender, rural area/farm, water well, and septic tank were associated 
with HEV seropositivity. Conclusions: This study revealed a high exposure rate to HEV in Croatian liver recipients.
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Hepatitis E virus (HEV) infection rate is increasing in 
several European countries, including reports of infection in 
immunocompromised patients, who may develop chronic HEV 
infections with rapid progression of disease and cirrhosis, after 
solid-organ transplantation (SOT)1. Zoonotic genotypes 3 and 
4 are endemic in Europe and hyperendemic in Southern France 
where foodborne transmissions are most common, primarily 
due to consumption of raw and undercooked meat of domestic 
pigs, wild boar, and deer2. 
Epidemiological studies from Europe estimate that HEV 
seroprevalence among SOT recipients differs widely, ranging 
from 2.7% to greater than 43%3,4. The large heterogeneity 
in seropositivity may be partially due not only to regional 
differences but also to differences in the sensitivity and 
specificity of immunoassays used to detect HEV antibodies. 
Data on HEV epidemiology, routes of transmission, and 
associated risk factors in solid-organ transplant cohorts in 
Southeast Europe are largely unknown.
Croatia has an increasing transplant population, which 
according to the International Registry in Organ Donation and 
Transplantation is estimated to be 28.2 liver transplantations 
(LTs) per million population, one of the highest LT rates in the 
world currently5. In Croatia, HEV seroprevalence in different 
population groups (alcohol abusers, war veterans, injecting drug 
users, and healthcare professionals) is estimated to be 8.9%, 
8.6%, 6.1%, and 2.7%, respectively6. 
This cross-sectional study aimed to determine the HEV 
seroprevalence and the possible sociodemographic and risk 
factors associated with HEV infection in a large cohort of 
Croatian liver transplant recipients.
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The study was conducted from June to October 2017 and 
included 242 adult liver recipients, transplanted from 1994 
to 2013 at the Liver Transplant Centre, Merkur University 
Hospital (Zagreb, Croatia), which is a high-volume transplant 
center with approximately 120 performed liver transplants 
yearly, representing over 90% of LTs in the country. All 
participants received the same immunosuppressive protocol, 
comprising calcineurin inhibitors, steroids (discontinued after 3 
months), and mycophenolate mofetil, after transplantation. The 
sociodemographic data and potential risk factors were collected 
by interviewing all the participants using a questionnaire. 
Medical data were collected from patients’ medical records.
Serum samples were tested for the presence of HEV 
antibodies and HEV ribonucleic acid (RNA) during routine 
visits to the outpatient transplant clinic. All samples were 
initially tested for the presence of HEV immunoglobulin G 
(IgG) antibodies. IgG reactive samples were further tested for 
the presence of HEV immunoglobulin M (IgM) antibodies 
to confirm/rule out recent infection. Serological testing 
was performed using commercial enzyme immunoassays 
(recomWell HEV IgG/IgM, Mikrogen, Neuried, Germany) 
and using highly purified HEV open reading frame - ORF2 
(genotype 1 and genotype 3) antigens. Manufacturer reveals a 
diagnostic sensitivity of 98.9% and a specificity of 98.5%. HEV 
seroprevalence rate prior to the transplantation was unknown.
Additionally, all samples were tested for the presence of 
HEV RNA. RNA extraction was performed using a QIAamp 
viral RNA extraction kit (Qiagen, Hilden, Germany), whereas 
reverse transcription was performed using the GoScript Reverse 
Transcription System for reverse transcription polymerase chain 
reaction (RT-PCR) (Promega, Madison, USA) in a GeneAmp 
PCR System 9700 machine (Applied Biosystems, USA). All 
samples were tested using a real-time PCR that targets an RNA 
sequence within the highly conserved ORF3 genome region.
The study was approved by the Hospital Ethics Committee. 
Each patient provided written informed consent for inclusion 
in the study.
Statistical analysis was performed using Stata/IC ver. 14.2 
(StataCorp LLC). Normality of distributions was assessed 
using Shapiro-Wilk test. Differences between the groups were 
tested using chi-squared and Fischer’s exact tests (categorical 
variables) or Mann-Whitney U and Kruskal-Wallis tests 
(ordinal or numerical variables). The association between the 
HEV seroprevalence and potential risk factors was tested using 
univariate and multiple logistic regression models. Level of 
statistical significance was set at α=0.05. 
HEV IgG antibodies were detected in 59/242 (24.4%) of 
transplant patients after LT. The median time after transplant 
was 5 years (range, 3-14 years). HEV IgM antibodies were noted 
in one patient, and one patient showed equivocal result. None 
of the tested sample was positive for HEV RNA, excluding 
acute, but more importantly chronic hepatitis E infection, 
which may develop in immunocompromised population and 
lead to graft loss.
There were no differences between the anti-HEV IgG-
positive and IgG-negative groups regarding the etiology of 
liver disease, area of residence, profession, and eating habits. 
Anti-HEV IgG-positive patients were older (median 62 vs. 59 
years, p=0.010) and more predominantly female (37.3% vs. 
18.6%, p=0.003) and had more household sewage systems 
connected to a septic tank compared to anti-HEV IgG-
negative patients (55.6% vs. 38.1%, p=0.027). In a group of 
anti-HEV IgG-seropositive patients, 88.9% had primary or 
lower secondary education compared to 75.0% in a group of 
anti-HEV-seronegative patients (p=0.024) (Table 1). According 
to a univariate logistic regression model, factors associated 
with anti-HEV IgG seropositivity in transplant patients were 
female gender (odds ratio [OR], 2.61; 95% confidence interval 
[CI], 1.42-4.81), older age (with each year’s increase in age) 
(OR, 1.05; 95% CI, 1.02-1.09), and a household sewage system 
connected to a septic tank (OR, 2.03; 95% CI, 1.09-3.78) 
(Table 2). After adjusting for age and gender, a rural area of 
residence (adjusted OR [AOR], 2.17; 95% CI, 1.10-4.27), a farm 
within a household (AOR, 2.79; 95% CI, 1.31-5.92), use of well as 
the source of drinking water (AOR, 3.09; 95% CI, 1.11-8.57), and 
sewage system connected to a septic tank (AOR, 3.38; 95% 
CI, 1.64-6.95) were associated anti-HEV IgG seroprevalence. 
Production and consumption of cured and undercooked meat, 
occupational exposure, and the number of household members 
were not significantly associated with anti-HEV IgG seropositivity 
(Table 2). In the multiple logistic regression model, independent 
risk factors for anti-HEV IgG seropositivity were female gender 
(OR, 4.13; 95% CI, 2.03-8.37), older age (OR, 1.05; 95% CI, 
1.01-1.09), and sewage system connected to a septic tank 
(AOR, 3.38; 95% CI, 1.64-6.95), whereas the highest level of 
education was identified as a protective factor (OR, 0.06; 95% 
CI, 0.01-0.54) (Table 3).
This is the first cross-sectional study assessing the anti-HEV 
IgG seroprevalence and associated risk factors in Croatian liver 
transplant patients. The results of this study showed a prevalence 
rate of 24.4% in transplant cohorts, suggesting a high degree of 
previous exposure to HEV. 
Studies on anti-HEV IgG seroprevalence in liver recipients in 
Europe reported variable prevalence rates. Moderate prevalence 
rates have been found in Germany (4%)7 and Spain (2.7%)3. 
Posttransplant anti-HEV IgG prevalence rate in Croatian 
patients is consistent to those reported from France, which has 
the highest HEV seroprevalence rates in Europe ranging up to 
29% in adult liver recipients8. Variations in HEV seroprevalence 
between countries may reflect not only the differences in viral 
circulation within a geographical region but also the impact of 
assays used in particular studies; therefore, the data should be 
cautiously interpreted. 
Results of this study showed that female gender, older age, 
rural type of living area, farm within a household, water well as a 
supply system, and a septic tank within a household sewage system 
were associated with anti-HEV IgG seropositivity in the univariate 
risk analysis. On the contrary, the highest educational level and a 
recent travelling experience as markers for a higher socioeconomic 
status were inversely related with HEV seropositivity. A similar 
inverse correlation between HEV seropositivity rates and the level 
of education was observed in other studies9.
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TABLE 1: Seroprevalence of hepatitis E virus in Croatian liver transplant recipients according to sociodemographic characteristics and risk factors.
Characteristics HEV IgG negative N (%) HEV IgG positive  N (%) p
Gender 0.003
     Male 136 (81.4) 31 (18.6)
     Female 47 (62.7) 28 (37.3)
Age at sampling, yrs median 59 (32-80) 62 (40-75) 0.010
Time after transplant, yrs median 6 (3-22) 5 (3-14) 0.609
Etiology of liver disease before LT 0.241
     Hepatitis B or C 39 (21.3) 10 (16.9)
     Alcoholic cirrhosis 94 (51.4) 28 (47.5)
     Autoimmune cirrhosis 19 (10.4) 9 (15.3)
     Metabolic diseases 8 (4.4) 0
     Cryptogenic liver disease 12 (6.6) 8 (13.6)
     Other liver diseases 11 (6.0) 4 (6.8)
Geographic region 0.210
     Continental 124 (67.8) 39 (66.1)
     Coastal 59 (32.2) 19 (32.2)
Educational level* 0.024
     ISCED 1 37 (22.0) 18 (33.3)
     ISCED 2 89 (53.0) 30 (55.6)
     ISCED 3-4 13 (7.7) 5 (9.3)
     ISCED 5-6 29 (17.3) 1 (1.9)
Number of household members
     1 14 (8.3) 3 (5.6)
0.809     2-4 127 (75.6) 41 (75.9)
     5 or more 26 (15.5) 10 (18.5)
Type of living area 0.159
     Urban area 89 (53) 22 (40.7)
     Rural area 79 (47) 32 (59.3)
     Farm within a household 36 (21.4) 18 (33.3) 0.100
Food/eating habits
     Consumption of cured meat products 126 (75) 40 (74.1) 0.859
     Occupational exposure 22 (13.1) 7 (13) >0.999
Source of drinking water
     Public water supply system 134 (79.8) 37 (68.5)
0.249
     Water tank 1 (0.6) 1 (1.9)
     Water well 13 (7.7) 8 (14.8)
     Bottled water 13 (7.7) 7 (13)
     Natural spring 7 (4.2) 1 (1.9)
Sewage system
     Public sewage system 104   61.9 24 (44.4)
0.027
     Septic tank 64   38.1 30 (55.6
Travelling history (within the last 3 years) 57   33.9 9 (16.7) 0.017
*The International Standard Classification of Education (ISCED): 1, primary education; 2, lower secondary education; 3-4, upper and postsecondary non-
tertiary education; 5-6, tertiary education.
A slightly higher seroprevalence rate in females was also 
reported in a previous Croatian study6, while some European 
studies reported higher seropositivity in males10. The meta-
analysis on 73 European anti-HEV IgG seroprevalence studies 
showed that 45 of the 73 studies had no significant differences 
in HEV seroprevalence between genders11.
Consistent with other seroepidemiological studies11, our 
results showed that older age was associated with higher 
seroprevalence rates, suggesting a lifelong cumulative exposure 
to the virus. 
Rural area of residence was reported as a risk factor for HEV 
seropositivity in several studies6,12. Moreover, living in a rural 
area with a farm was associated with HEV seropositivity in our 
cohort of transplant patients. Croatian data show high HEV 
seroprevalence rates (up to 91.7%) and HEV RNA prevalence 
rate of 13.3% in domestic pigs13. The rural population is more 
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TABLE 2: Univariate logistic regression analysis of risk factors associated with anti-hepatitis E virus immunoglobulin G seropositivity among liver transplant 
recipients.
Exposure group/variables OR OR 95% CI AORa AOR 95% CI
Sex (female vs. male) 2.61 1.42-4.81
Age at sampling, yrs 1.05 1.01-1.09
Time after transplant, yrs 0.95 0.86-1.05 0.93 0.84-1.03
Etiology of liver disease before LT
     Hepatitis B or C Ref Ref
     Alcoholic cirrhosis 1.16 0.51-2.61 1.32 0.57-3.08
     Autoimmune cirrhosis  1.84 0.64-5.30 1.88 0.58-6.04
     Metabolic diseases  2.6 0.83-8.07 2.08 0.63-6.8
     Cryptogenic liver disease  1.42 0.37-5.41 1.27 0.30-5.39
Geographic region (coastal vs. continental) 1.02 0.55-1.92 1.17 0.611-2.24
Educational level (ISCED)**
     ISCED 1 Ref Ref
     ISCED 2 0.69 0.35-1.39 0.72 0.33-1.53
     ISCED 3-4 0.79 0.24-2.56 1.06 0.31-3.63
     ISCED 5-6 0.07 0.01-0.56 0.05 0.01-0.43
Number of people living in a household
     1 Ref Ref
     2-4 1.51 0.41-5.05 1.34 0.35-5.2
     5 or more 1.80 0.42-7.61 1.60 0.35-7.30
Type of living area (rural vs. urban) 1.64 0.88-3.05 2.17 1.10-4.27
Farm within a household (yes vs. no) 1.83 0.93-3.60 2.79 1.31-5.92
Consumption of cured meat products (yes vs. no) 0.95 0.47-1.92 1.43 0.66-3.09
Occupational exposure (yes vs.no) 0.98 0.39-2.46 1.76 0.66-4.69
Source of drinking water
     Public water supply system Ref Ref
     Water tank 3.62 0.22-59.29 4.17 0.24-71.58
     Water well 2.23 0.86-5.78 3.09 1.11-8.57
     Bottled water 1.95 0.73-5.24 1.23 0.43-3.57
     Natural spring 0.52 0.061-4.34 0.61 0.069-5.41
Sewage system
     Public sewer system Ref Ref
     Septic tank 2.03 1.09-3.78 3.38 1.64-6.95
Travelling experience within the last 3 years (yes vs. no) 0.39 0.18-0.85 0.39 0.17-0.88
aEach model adjusted for age and gender; AOR, adjusted odds ratio. *Referent. **The International Standard Classification of Education (ISCED): 1, primary 
education; 2, lower secondary education; 3-4, upper and postsecondary non-tertiary education; 5-6, tertiary education.
TABLE 3: Multivariate logistic regression analysis of risk factors associated with anti-hepatitis E virus immunoglobulin G seropositivity among liver transplant 
recipients. 
Exposure group/variables OR 95% CI p
Age, (one year increase) 1.07 1.02-1.11 0.004
Sex (female vs. male) 5.65 2.60-12.28 <0.001
Sewage system (public sewer system vs. septic tank) 3.05 1.39-6.66 0.005
Educational level**
     ISCED 1 Ref
     ISCED 2 0.94 0.42-2.09 0.886
     ISCED 3-4 1.99 0.52-7.55 0.308
     ISCED 5-6 0.084 0.09-0.73 0.005
**The International Standard Classification of Education (ISCED): 1, primary education; 2, lower secondary education; 3-4, upper and postsecondary non-
tertiary education; 5-6, tertiary education.
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often in contact with pigs than the urban population; therefore, 
the probability of exposure to HEV is higher in the rural 
population compared to the urban population. 
Additionally, the use of the stream/well as a source of water 
was identified as a risk factor in some countries14. Approximately 
14% of the population in Croatia is using drinking water from 
individual water wells or cisterns. In a group of liver transplant 
patients presented in this study, 7.7% used a well as the source 
of drinking water, and 38.1% used septic tanks within the 
household sewage system. Both factors were found to be 
associated with HEV seroprevalence.
Consumption of contaminated pork products is one of the 
well-known risk factors for human HEV infection. Production 
and consumption of cured and thermally unprocessed meat 
and occupational exposure were associated with anti-HEV IgG 
seropositivity in some studies15, which was not established in 
our cohort of transplant patients. 
This study has some limitations that need to be addressed. 
Determining anti-HEV IgG and IgM seroprevalence rate is 
important in assessing past and recent infections. However, 
in immunocompromised patients such as liver transplant 
recipients, immunosuppressive therapy may compromise 
humoral immune response and limit the diagnostic value of 
serology. In these cases, RT-PCR is required to establish an 
active infection. Moreover, the study included a relatively small 
number of patients; therefore, the results should be cautiously 
interpreted. Despite these limitations, this is the first study 
on anti-HEV prevalence in Croatian liver transplant recipients 
that offers new insights into HEV epidemiology in this 
population group. 
In conclusion, the results of this study showed that anti-HEV 
IgG seroprevalence rate in Croatian liver transplant patients 
is high (24.4%) and is consistent with the prevalence rates in 
other endemic regions in Europe. Older age, female gender, 
living in a rural area with a farm as a household setting, using 
a water well as a main water supply system, and using a septic 
tank within a household sewage system were identified as the 
main risk factors associated with HEV seropositivity. Further 
studies on a large number of SOT recipients are needed to 
confirm these observations and define the prevalence, clinical 
significance, and routes of transmission of HEV infection in 
high-risk population groups.
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